BONE MARROW SAMPLING FROM NORMAL SUBJECTS

正常受试者的骨髓取样

• 批准号: 7379302
• 负责人: DAVID Chandler DALE
• 金额: $ 2.23万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-04-01 至 2007-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7379302
• 关键词: BONE; MARROW; SAMPLING; NORMAL; SUBJECTS

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to assess the effects of recombinant human granulocyte colony stimulating factor in patients with congenital neutropenia, chronic idiopathic neutropenia, and cyclic neutropenia by assessment of occurrence of infections, inflammation and side effects. Under this protocol, investigations of the molecular and cellular basis for SCN continue as well as continued clinical observations of patients on long-term treatment with G-CSF and other therapies.

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。本研究的目的是评估重组人粒细胞集落刺激因子对先天性中性粒细胞减少症、慢性特发性中性粒细胞减少症和周期性中性粒细胞减少症患者的感染、炎症和副作用的发生情况。在该方案下，继续研究SCN的分子和细胞基础，并继续对长期接受G-CSF和其他疗法治疗的患者进行临床观察。